Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone SR/Bupropion SR (Contrave)

· Orexigen Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naltrexone SR/Bupropion SR (Contrave), covering 2014-11-21 to 2014-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects [Phase 3]

See pricing